Title:
がん免疫アジュバント
Document Type and Number:
Japanese Patent JPWO2018021400
Kind Code:
A1
Abstract:
本発明は免疫チェックポイント阻害剤とアジュバント組成物を組み合わせて含む、がん又は感染症を治療するための医薬に関する。より詳細には、抗ＰＤ−１抗体又は抗ＰＤ−Ｌ１抗体と、二本鎖ＲＮＡと一本鎖ＯＤＮから構成される核酸アジュバントを併用することを特徴とする、がん又は感染症の医薬に関する。
More Like This:
| WO/2023/196188 | IMMUNE ENHANCEMENT OF CANCER TREATMENT |
| JP2016222700 | COMBINATION THERAPIES FOR HEMATOLOGIC MALIGNANCIES |
| JP3268147 | MONOCLONAL ANTIBODY |
Inventors:
Seya Tsukasa
Misako Matsumoto
Misako Matsumoto
Application Number:
JP2018530349A
Publication Date:
May 23, 2019
Filing Date:
July 26, 2017
Export Citation:
Assignee:
Next Generation Innovation Development Co., Ltd.
International Classes:
A61K39/395; A61K39/39; A61P31/04; A61P35/00; A61P37/04; A61P43/00
Domestic Patent References:
| JP2014527983A | 2014-10-23 |
Foreign References:
| WO2016019472A1 | 2016-02-11 | |||
| WO2012014945A1 | 2012-02-02 | |||
| WO2016088784A1 | 2016-06-09 |
Other References:
瀬谷司、松本美佐子: "プライミングアジュバントの開発−副作用の少ない免疫療法の確立に向けて", 医学のあゆみ, vol. 256, no. 7, JPN6017037448, 13 February 2016 (2016-02-13), pages 811 - 816, ISSN: 0004634756
CLINICAL CANCER RESEARH, vol. 20, no. 5, JPN6021040895, 2014, pages 1223 - 1233, ISSN: 0004634757
CANCER RESEARCH, vol. Vol.74(19 Suppl), JPN6021040894, 2014, pages 5018, ISSN: 0004634758
CLINICAL CANCER RESEARH, vol. 20, no. 5, JPN6021040895, 2014, pages 1223 - 1233, ISSN: 0004634757
CANCER RESEARCH, vol. Vol.74(19 Suppl), JPN6021040894, 2014, pages 5018, ISSN: 0004634758
Attorney, Agent or Firm:
Seiji Ohno
Kenichi Katayama
Yuko Matsuniya
Kenichi Katayama
Yuko Matsuniya
Previous Patent: An attachment auxiliary tool and an elastic device
Next Patent: Joining structure of a structure main part of a timber building
Next Patent: Joining structure of a structure main part of a timber building